Funded Startups in Westlake Village
Velocity Financial’s $500M round (2026-01-28) is the only disclosed deal above $100M in this set, and it dwarfs the next-largest disclosed amount of $300M…
Velocity Financial’s $500M round (2026-01-28) is the only disclosed deal above $100M in this set, and it dwarfs the next-largest disclosed amount of $300M for LTC (2026-06-30). The disclosed amounts also cluster into two temporal edges: several of the largest checks land in 2025–2026 (e.g., Angitia Biopharmaceuticals $130M on 2026-02-05; Ember Technologies $24M on 2021-12-01), while the oldest disclosed figures include A2 Biotherapeutics’ $72M (2020-10-06) and Eta Compute’s $13M (2020-12-15). All entries list Westlake Village, United States/California, so geographic variation is limited to sector and stage rather than location. Sector-wise, financial services appears in multiple entries (Velocity Financial, Avinew, Warner Pacific), and “Series Unknown” is a recurring classification for deals like Precise Behavioral (2026-07-29, $14M) and LTC (2026-06-30, $300M).
Most recent rounds
18 shownRelated listings
Frequently asked
Which deal is the largest disclosed amount in Westlake Village, and how separated is it from the rest?
The largest disclosed round is Velocity Financial’s $500M (2026-01-28). The next-largest disclosed amount is LTC’s $300M (2026-06-30), meaning the top two are already far apart and $130M (Angitia Biopharmaceuticals on 2026-02-05) drops to the next level.
Do the most recent financings cluster into a narrow date window?
Yes. In the most recent ~90 days of the dataset, disclosed checks include Precise Behavioral’s $14M (2026-07-29), LTC’s $300M (2026-06-30), and ONclick Healthcare’s $3M (2026-05-06). Earlier, the disclosed highs are still present but spread, with A2 Biotherapeutics’ $72M (2020-10-06) and Eta Compute’s $13M (2020-12-15) anchoring the oldest edge.
Are any sectors over-represented compared with others?
Financial Services shows up repeatedly: Velocity Financial ($500M, 2026-01-28), Avinew (Corporate Round, 2022-05-10, amount undisclosed), and Warner Pacific (Private Equity, 2022-01-13, $100K). Other single-sector standouts include Biotechnology (e.g., Angitia Biopharmaceuticals $130M on 2026-02-05; A2 Biotherapeutics $72M on 2020-10-06).
How much of the list is disclosed vs. undisclosed, and what does that imply for outlier detection?
15 of 18 entries have disclosed amounts, while 3 are undisclosed (including Cognify on 2026-07-13 and PureSpectrum on 2026-01-06). With undisclosed rows excluded from comparisons, the $500M (Velocity Financial) and $300M (LTC) outliers are clear among disclosed deals.
What does the stage mix look like, and is “Series Unknown” a dominant label?
“Series Unknown” appears frequently in the rows with disclosed amounts, including Precise Behavioral ($14M, 2026-07-29) and Velocity Financial ($500M, 2026-01-28), as well as LTC ($300M, 2026-06-30). Other stages include named rounds like Series D (Angitia Biopharmaceuticals $130M, 2026-02-05) and Series E (Ember Technologies $24M, 2021-12-01), but they do not occur as consistently as the unknown classification.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.